Early detection of lung cancer is challenging because symptoms often do not appear until the disease has progressed, and when they do, they may be mistaken for less serious conditions, emphasized ...

The FDA has granted breakthrough therapy designation to ficerafusp alfa with Keytruda for some patients with head and neck squamous cell carcinoma.

The U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant) for the treatment of adults with estrogen ...